Literature DB >> 6849813

Experimental production of pulmonary granulomas. IV. Eosinophilic granuloma.

Y Hamamoto, K Kinoshita, K Hashimoto, T Matsushita, K Kogishi, K Yasuhira.   

Abstract

Pulmonary granulomas induced in rabbits by the endobronchial instillation of mycobacterial chemical fractions were re-examined for eosinophilic infiltration. Delayed type hypersensitivity reactions either of tuberculin type or of wax D type did not induce but rather suppressed eosinophilic infiltration in the inflamed area, although some peptidoglycans which are antigenic for the induction of immediate hypersensitivity and fatty acid fractions were weak stimulators of eosinophilic infiltration. Bacterial endotoxin, LPS, was a potent stimulator. It was found that some long chain fatty acids can cause severe eosinophilic infiltration in the induced granulomas. Arachidonic acid was the most active of those examined, so the activity of its metabolites was tested and PGE2 was found to be most active. As the eosinophilic infiltration was markedly suppressed in animals treated with a cyclooxygenase inhibitor (aspirin), the stimulators of eosinophilic infiltration were not fatty acids themselves but their metabolites, PGE2 and some others. The site of permeation of eosinophils from the circulation was found to be arteriolar in the inflamed lung. The granulomatous lesion with eosinophilic infiltration in rabbits is discussed to shed light on the aetiology of eosinophilic granuloma in the human lung.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6849813      PMCID: PMC2040681     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  8 in total

1.  Eosinophilic granuloma of the lung.

Authors:  M VIRSHUP; A GOLDMAN
Journal:  J Thorac Surg       Date:  1956-02

2.  Histiocytosis X; integration of eosinophilic granuloma of bone, Letterer-Siwe disease, and Schüller-Christian disease as related manifestations of a single nosologic entity.

Authors:  L LICHTENSTEIN
Journal:  AMA Arch Pathol       Date:  1953-07

3.  Eosinophils and immune mechanisms. Eosinophil stimulation promoter (ESP): a lymphokine induced by specific antigen or phytohemagglutinin.

Authors:  D G Colley
Journal:  J Immunol       Date:  1973-05       Impact factor: 5.422

4.  Stimulation of human eosinophil and neutrophil polymorphonuclear leukocyte chemotaxis and random migration by 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid.

Authors:  E J Goetzl; J M Woods; R R Gorman
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

5.  Experimental production of pulmonary granulomas. I. Immune granulomas induced by chemically modified cell walls and their constituents.

Authors:  Y Hamamoto; Y Kobara; A Kojima; Y Kumazawa; K Yasuhira
Journal:  Br J Exp Pathol       Date:  1981-06

6.  Purification and synthesis of eosinophilotactic tetrapeptides of human lung tissue: identification as eosinophil chemotactic factor of anaphylaxis.

Authors:  E J Goetzl; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

7.  In vitro and in vivo activity of a lymphocyte and immune complex-dependent chemotactic factor for eosinophils.

Authors:  S Cohen; P A Ward
Journal:  J Exp Med       Date:  1971-01-01       Impact factor: 14.307

8.  An eosinophil leukocyte chemotactic factor of anaphylaxis.

Authors:  A B Kay; D J Stechschulte; K F Austen
Journal:  J Exp Med       Date:  1971-03-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.